Invasive urothelial carcinoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Invasive urothelial carcinoma
Synonyms	Transitional cell carcinoma
Pronounce	N/A
Specialty	N/A
Symptoms	Hematuria, dysuria, pelvic pain
Complications	Metastasis, urinary obstruction
Onset	Typically in older adults
Duration	Chronic
Types	Non-muscle invasive, muscle invasive
Causes	Smoking, chemical exposure, chronic bladder inflammation
Risks	Tobacco use, occupational exposure, family history
Diagnosis	Cystoscopy, biopsy, imaging studies
Differential diagnosis	Bladder infection, benign prostatic hyperplasia, kidney stones
Prevention	Smoking cessation, protective equipment in workplaces
Treatment	Surgery, chemotherapy, radiation therapy
Medication	Cisplatin, gemcitabine, immunotherapy
Prognosis	Variable, depends on stage and grade
Frequency	Common in developed countries
Deaths	Significant, especially in advanced stages

Invasive urothelial carcinoma is a form of bladder cancer that originates in the urothelium, a layer of tissue that lines the bladder and other parts of the urinary tract. This type of carcinoma is characterized by its ability to invade the muscular wall of the bladder, which can lead to a more aggressive disease and a higher risk of metastasis compared to non-invasive forms of bladder cancer.

Etiology

The exact cause of invasive urothelial carcinoma is not fully understood, but several risk factors have been identified. These include smoking, exposure to certain chemicals used in the dye industry, chronic irritation of the bladder lining, and a history of urinary tract infections or bladder stones. Genetic predisposition may also play a role in the development of this cancer.

Symptoms

Common symptoms of invasive urothelial carcinoma include blood in the urine (hematuria), painful urination, frequent urination, and urgency to urinate. These symptoms are not specific to bladder cancer and can be associated with other, less serious conditions. However, any persistent symptoms should be evaluated by a healthcare provider.

Diagnosis

Diagnosis of invasive urothelial carcinoma typically involves a combination of cystoscopy, where a scope is used to visually inspect the bladder, and biopsy, where tissue samples are taken for microscopic examination. Imaging tests such as CT scans, MRI, and ultrasounds may also be used to assess the extent of the cancer and whether it has spread to other parts of the body.

Treatment

Treatment options for invasive urothelial carcinoma depend on the stage of the cancer and may include surgical removal of the tumor, chemotherapy, radiation therapy, or a combination of these methods. In more advanced cases, where the cancer has invaded the muscle layer of the bladder or spread to other areas, a radical cystectomy, which is the removal of the entire bladder, may be necessary.

Prognosis

The prognosis for invasive urothelial carcinoma varies depending on the stage at diagnosis and the effectiveness of the treatment. Early detection and treatment are crucial for improving outcomes. Regular follow-up is important to monitor for recurrence of the cancer.

Prevention

Preventive measures for invasive urothelial carcinoma include avoiding known risk factors such as smoking and exposure to certain chemicals. Regular screening may be recommended for individuals at high risk.

   This article is a oncology stub. You can help WikiMD by expanding it!